Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients of at least 18 years at the time of consent~* Patients with a venous leg ulcer (Ulcus cruris)~* Patients with a chronic leg ulcer~* Females of childbearing potential who are willing to comply with any applicable contraceptive requirements of the protocol~* Negative pregnancy test~* Satisfactory medical assessment~* Ability to provide written informed consent~* Signed declaration of consent~* Willingness to co-operate~Exclusion Criteria:~* Pregnant or lactating women and women not using contraception~* Known history of alcohol or drug abuse~* Use of any antibiotic medication within the last 7 days prior to the first dose~* Patients with serious concomitant disease~* Patients with a coagulation disorder~* Known history of allergic reactions attributed to octenisept® or one of its compounds~* Participation in another clinical trial within the last 30 days before randomization~* Concomitant treatment with other preparations that interfere with the trial preparation or the disease~* Absence of declaration of consent~* Doubt about willingness to co-operate~* Non-fulfilment of the inclusion criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- verum (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).